Valuation, from the filing
| Public float | $1.13B | Market value of stock held by non-affiliates, as stated on the cover page for 2025-06-30 |
|---|---|---|
| Float / revenue | 0.6× | A lower bound on the multiple, because affiliate holdings are excluded. |
| Float / equity | 3.7× | A lower bound on the multiple, because affiliate holdings are excluded. |
Every figure here is drawn from the 10-K cover page and the statements behind it, so each one traces to a filing. Public float counts only stock held by non-affiliates, which makes these floors rather than estimates: a high multiple is conclusive, a low one may mean cheap or may mean closely held. The float was measured on 2025-06-30, not today, and each multiple below it uses the figures for the fiscal year ending 2025-12-31 — the year that filing covered.
How this compares in its industry
Percentile among the Hospital & Medical Service Plans filers on this site, highest value first. A high percentile means a large figure, which is good for a margin and not for leverage — the ranking says where the company sits, not whether that is where it should be.
| Measure | Reported | Percentile | |
|---|---|---|---|
| CapEx / revenue | 0.1% | 0th | |
| FCF margin | -3.6% | 0th | |
| Net margin | -4.4% | 0th | |
| Operating margin | -4.4% | 0th | |
| SBC / revenue | 5.4% | 100th | |
| Revenue YoY growth | 40.3% | 89th | |
| Current ratio | 1.47x | 44th |
CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) reported revenue of $2.48B for the fiscal year ended 2026-06-30. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from CLOVER HEALTH INVESTMENTS, CORP. /DE’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Hospital & Medical Service Plans.
Banks, brokers and insurers present a top line that is not comparable with an operating company’s revenue: it is reported net of interest expense, or as premiums earned, depending on the filer. The figures are the filer’s own and are traceable to the filing; the comparison across classes is what does not hold.
Income
| Metric | 2026-06-30 |
|---|---|
| Revenue | $2.48B |
| Cost of revenue | Unavailable |
| Gross profit | Unavailable |
| Operating income | -$18.36M |
| Net income | Unavailable |
| Research & development | Unavailable |
| Weighted-average diluted shares | Unavailable |
| Pretax income | Unavailable |
| Income tax expense | Unavailable |
| Diluted EPS | Unavailable |
| Selling, general & administrative | Unavailable |
| General & administrative | $260.04M |
| Selling & marketing | Unavailable |
Balance
| Metric | 2026-06-30 |
|---|---|
| Cash & equivalents | Unavailable |
| Total assets | $720.33M |
| Current assets | $485.45M |
| Total liabilities | $344.07M |
| Current liabilities | $323.33M |
| Total equity incl. NCI | $376.26M |
| Temporary (mezzanine) equity | Unavailable |
| Inventory | Unavailable |
| Accounts receivable | Unavailable |
| Goodwill | Unavailable |
| Long-term debt | Unavailable |
| Accounts payable | Unavailable |
Cash flow
| Metric | 2026-06-30 |
|---|---|
| Operating cash flow | $77.03M |
| Capital expenditures | $2.82M |
| Investing cash flow | -$45.52M |
| Financing cash flow | -$21.32M |
| Net change in cash | $10.19M |
| Stock-based compensation | $72.38M |
| Common dividends paid | Unavailable |
| Common share repurchases | $1.00K |
| Depreciation & amortization | $1.90M |
Derived
| Metric | 2026-06-30 |
|---|---|
| Free cash flow | $74.21M |
| Gross margin | Unavailable |
| Operating margin | -0.7% |
| FCF margin | 3.0% |
| SBC / revenue | 2.9% |
| Current ratio | 1.50x |
| Revenue YoY growth | 54.0% |
| Net margin | Unavailable |
| R&D / revenue | Unavailable |
| CapEx / revenue | 0.1% |
| Long-term debt / equity | Unavailable |
| Effective tax rate | Unavailable |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open CLOV in the interactive workspace to inspect any figure back to its filing.
Source filings
Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.